Ina Drug Patent Portfolio
Ina owns 1 orange book drug protected by 3 US patents Given below is the list of Ina's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8232276 | Anhydrous topical skin preparations | 24 Nov, 2020 | Expired |
| US7179475 | Anhydrous topical skin preparations | 04 Dec, 2018 | Expired |
| US8735393 | Anhydrous topical skin preparations | 04 Dec, 2018 | Expired |
Latest Legal Activities on Ina's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ina.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent | 02 Sep, 2024 | US8232276 |
|
Maintenance Fee Reminder Mailed
Critical
| 18 Mar, 2024 | US8232276 |
| Expire Patent | 04 Jul, 2022 | US8735393 |
| Maintenance Fee Reminder Mailed | 17 Jan, 2022 | US8735393 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Dec, 2019 | US8232276 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Nov, 2017 | US8735393 |
| Recordation of Patent Grant Mailed | 27 May, 2014 | US8735393 |
| Patent Issue Date Used in PTA Calculation | 27 May, 2014 | US8735393 |
| Email Notification | 08 May, 2014 | US8735393 |
| Issue Notification Mailed | 07 May, 2014 | US8735393 |
| Dispatch to FDC | 25 Apr, 2014 | US8735393 |
| Application Is Considered Ready for Issue | 24 Apr, 2014 | US8735393 |
| Email Notification | 17 Apr, 2014 | US8735393 |
| Mail PUB Notice of non-compliant IDS | 17 Apr, 2014 | US8735393 |
| PUB Notice of non-compliant IDS | 15 Apr, 2014 | US8735393 |
Ina's Drug Patent Litigations
Ina's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jun 22, 2009, against patent number US8232276. The petitioner , challenged the validity of this patent, with Katherine M. Burnett et al as the respondent. Click below to track the latest information on how companies are challenging Ina's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8232276 | June, 2009 |
Decision
(17 May, 2010)
| Katherine M. Burnett et al | |
Ina's Family Patents
Clinical Trials
Recent Clinical Trials by Ina:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| CREON for the Treatment of Post-RYGB Hypoglycemia | East Carolina University | NA |
TERMINATED
(Oct, 2023)
| PHASE1 |
| Alexa, What is Eliquis and Xarelto? | Cedars-Sinai Medical Center | NA |
TERMINATED
(Mar, 2022)
| NA |
Ina Drug List
Given below is the complete list of Ina's drugs and the patents protecting them.
1. Xolegel
Xolegel is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8232276 | Anhydrous topical skin preparations |
24 Nov, 2020
(5 years ago)
| Expired |
| US7179475 | Anhydrous topical skin preparations |
04 Dec, 2018
(7 years ago)
| Expired |
| US8735393 | Anhydrous topical skin preparations |
04 Dec, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xolegel's drug page